Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

J&J unit to resolve charity kickback probe

A unit of Johnson & Johnson will pay $360 million to resolve an investigation into the company’s financial support of a charity that helped Medicare patients cover out-of-pocket drug costs.

Read More »

Clovis Oncology, execs to pay $20 million to settle SEC charges

U.S. biotechnology company Clovis Oncology Inc., Chief Executive Patrick Mahaffy, and former CFO Erle Mast will pay more than $20 million to settle charges of misleading investors about the efficacy of a cancer drug, the top U.S. securities regulator said.

Read More »

SEC Charges Osiris, Four Former Execs With Accounting Fraud

Osiris Therapeutics settled a case of accounting fraud with the U.S. SEC, but four former company executives will face charges for the alleged financial misreporting.

Read More »

UnitedHealth sued by U.S. government over Medicare charges

The U.S. Justice Department joined a whistleblower lawsuit against UnitedHealth Group Inc. that claims the country’s largest health insurer and its units and affiliates overcharged Medicare hundreds of millions of dollars, a law firm representing the whistleblower said.

Read More »

Turkey’s investigation into Novartis ‘ongoing’

Turkey’s investigation into Novartis for bribery allegations is “ongoing,” a Turkish health ministry official told Reuters, after the drugmaker said it was not under investigation.

Read More »

Justice Department unveils ‘largest takedown ever’ to combat Medicare fraud

Attorney General Loretta E. Lynch stands during the announcement of law enforcement action against the state of North Carolina in Washington, U.S., May 9, 2016. Reuters/Joshua Roberts/File Photo The U.S. Justice Department said Wednesday that federal law enforcement officials have hit a milestone in 2016 by completing the “largest takedown ever” against defendants allegedly trying […]

Read More »

Turkish prosecutor opens bribery probe into drugmaker Novartis

The Ankara Chief Prosecutor has launched an investigation into the Turkish unit of Swiss drugmaker Novartis after allegations the company benefited from bribery.

Read More »

Renaissance RX Faces New Employee Lawsuit, Fraud Allegations

February 18, 2016 By Alex Keown, BioSpace.com Breaking News Staff   NEW ORLEANS — The once promising Renaissance RX, a personalized medicine firm specializing in genetic testing, is facing allegations of fraud in an employee lawsuit, the Advocate of Louisiana reported Wednesday. Alison Diboll, who relocated to New Orleans from California to take a marketing […]

Read More »

INSYS Responds to Allegations It Falsified Reports to Sell More of its Cancer Pain Treatment

PHOENIX – After its stock dropped nearly 20 percent, Insys Therapeutics defended its practices from allegations it falsified data in order to sell more of its painkiller, the fentanyl-based Subsys. The Arizona-based company said it is committed to patient safety and has complied with all law, including those related to adverse event reporting.   In […]

Read More »

Exclusive: GSK faces new corruption allegations, this time in Romania

Drugmaker GlaxoSmithKline, which was fined a record 3 billion yuan ($483 million) for corruption in China last year and is examining possible staff misconduct elsewhere, faces new allegations of bribery in Romania. GSK confirmed it was looking into the latest claims of improper payments set out in a whistleblower’s email sent to its top management […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2018 Focus: Top 50 Pharma, Company of the Year and more!

Subscribe

Ad Right Bottom